David J. Liewehr
ORCID: 0000-0002-1039-7713Also affiliated with National Cancer Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models”.
Xiaolin Wan, Jacob S. Roth, David J. Liewehr, Nancy E. Sealover, William J.E. Frye +29 more
John Glod, Melissa Spencer, Miki Kasai, Joanne Derdak, Eva Dombi +9 more
Ahmad Shafiei, David Venzon, David J. Liewehr, Michal Mauda Havanuk, Maran Ilanchezhian +11 more
Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo +14 more
Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo +14 more